Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹23,519 Cr
P/E Ratio
48.28
P/B Ratio
10.82
Industry P/E
57.71
Debt to Equity
0
ROE
21.27 %
ROCE
27.89 %
Div. Yield
0.85 %
Book Value
259.92
EPS
58.29
CFO
₹2,987.31 Cr
EBITDA
₹3,597.64 Cr
Net Profit
₹2,235.20 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| -6.44 | 3.90 | 3.34 | 19.56 | 7.12 | 12.56 | -- |
|
BSE Healthcare
| -7.90 | 2.97 | 1.44 | 19.90 | 23.14 | 22.25 | 9.69 |
|
BSE Mid Cap
| -5.72 | 8.58 | 6.80 | 6.59 | 25.47 | 30.63 | 15.39 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| 16.50 | 14.03 | -40.86 | 58.78 | 50.34 | 61.54 | 2.90 |
|
BSE Mid Cap
| 25.84 | 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 39.81 | 39.74 | 20.95 | -- | |
| 953.60 | 5,046.83 | 55.15 | 17.71 | |
| 989.60 | 10,182.55 | 71.17 | 18.92 |
The Backing of a Resilient Balance Sheet
5 min read•By Jugal Harpalani
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology,... electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India. Read more
Incorporated
1995
Chairman
Arvind Lal
Managing Director
--
Group
Arvind Lal
Headquarters
New Delhi, Delhi
Website
Looking for more details about Dr. Lal Pathlabs Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Dr Lal Pathlabs Ltd stood at ₹ 2,717 Cr as on 31-Mar-25
The share price of Dr Lal Pathlabs Ltd is ₹2,807.10 (NSE) and ₹2,813.55 (BSE) as of 12-May-2025 IST. Dr Lal Pathlabs Ltd has given a return of 7.12% in the last 3 years.
Dr Lal Pathlabs Ltd has a market capitalisation of ₹ 23,519 Cr as on 12-May-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Dr Lal Pathlabs Ltd is 10.82 times as on 12-May-2025, a 8% premium to its peers’ median range of 10.04 times.
The P/E ratio of Dr Lal Pathlabs Ltd is 48.28 times as on 12-May-2025, a 16% discount to its peers’ median range of 57.71 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Dr Lal Pathlabs Ltd and enter the required number of quantities and click on buy to purchase the shares of Dr Lal Pathlabs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
The promoters of Dr Lal Pathlabs Ltd are Arvind Lal and Vandana Lal. They collectively own 50.04 per cent of the total equity. The chairman of the company is Arvind Lal
There is no promoter pledging in Dr Lal Pathlabs Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,201
|
|
|
4,980
|
|
|
40
|
|
|
10,201
|
| Dr. Lal Pathlabs Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
23.34
|
|
Operating margin(%)
|
22.49
|
|
Net Margin(%)
|
19.27
|
|
Dividend yield(%)
|
0.85
|
Yes, TTM profit after tax of Dr Lal Pathlabs Ltd was ₹487 Cr.
₹32.70
(
